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Abstract
Many physiological parameters such as body temperature, circulating hormone levels,
blood pressure and metabolic activity are rhythmic, and their rhythmicity is governed by the
circadian clock. This is a self-sustained ~24-hour cycle, which at the molecular level is
determined by negative transcriptional and translational feedback loops controlled by the
products of core clock genes. There are at least 10 core clock genes namely Bmal1, Bmal2,
Clock, Npas2, Per1, Per2, Per3, Cry1, Cry2, Nr1d1 and Nr1d2. In addition to these core clock
genes, clock modifier genes exist that modulate the molecular clock by integrating synchronous
and asynchronous clues from signal transduction pathways. Nearly 1000 clock modifier genes
have been identified and among these is the chemotactic cytokine-like protein CKLF. shRNA
mediated down-regulation of Cklf conducted in U2OS cell lines exhibited short period length,
whereas its knockdown in MMH-D3 reporter cells resulted in decreased amplitude of oscillation,
suggesting a role for Cklf in regulating the oscillatory function of the clock. Since Cklf is an
immune mediator, this result suggests a functional interaction between the immune system and
the clock. To further investigate the interaction between Cklf and the core clock genes and to
determine how the circadian clock is integrated with and regulated by immune mediators, we
carried out knockout studies using the latest Crispr/Cas9 gene editing tool. Crispr/Cas9 is an
efficient genome editing tool that allows for genetic perturbation of individual genes with
enhanced specificity and efficacy of gene knockout compared to RNAi approaches. Using
Crispr/Cas9 method my work focused on knocking out Cklf and one of the core clock genes Cry2
in MMH-D3 reporter cell lines. We focused on Cry2 because it is one of the key proteins that
controls the period of the clock. We successfully knocked out Cry2 and showed that the
knockout cells exhibited long-period phenotype, confirming that Cry2 is core clock gene that
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functions to maintain the period of the clock to about 24 hours. In contrast, repeated efforts to
knock out Cklf using the Crispr/Cas9 approach was unsuccessful. Future work aims to obtain
Cklf knockout cell lines by improving the genome editing efficiency such as higher transfection
efficiency, expanding flow cytometry-based single cell sorting and cloning, and designing new
PCR genotyping strategies.
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Introduction
Inherent timing mechanisms which control the various physiological processes and
behavioral states of organisms are called biological clocks (Birky & Bray, 2014). The biological
oscillators occurring over a period of approximately 24 hours are known as circadian rhythms.
The oscillations are controlled by the endogenous circadian clocks. The characteristic features of
the circadian clock are that its periodicity persists under ambient conditions and in the absence of
environmental clues (Buhr & Takahashi, 2013). Another unique feature of the clock is its
robustness under different temperature conditions.
The master circadian pacemaker is located in the Suprachiasmatic Nucleus (SCN).
Circadian clocks are present in all cell types besides the SCN and are called the peripheral
clocks, which are coordinated and synchronized by the SCN clock (Partch, Green, & Takahashi,
2014). The molecular mechanism of the circadian clock in individual cells is based on a negative
transcriptional/translational feedback mechanism, known to consist of three feedback loops, each
of which are regulated by their own activators and repressors (Figure 1).
In the core feedback loop, the activators are Bmal1and Clock while the repressors are Per
and Cry which form time-of-day-dependent complexes that function to regulate the E-box ciselement-mediated transcription of genes (Takahashi, 2015). The positive limb of the loop is
composed of transcriptional activators BMAL1and CLOCK proteins which form heterodimers
and bind to the E-boxes present in the promoter region of target genes including Cry1,2 and
Per1,2,3. The PER and CRY proteins are the negative components of the
transcriptional/translational feedback loop; they in turn form heterodimers and enter the nucleus
to bind to BMAL1-CLOCK complex and inhibit their own transcription (Albrecht, 2012),
completing the loop. Since the negative components are involved in the regulation of their own
1

transcription, the circadian clock mechanism is a negative transcriptional/translational loop. The
repression phase ends when PER and CRY are degraded, leading to a new transcription cycle.
The period of the clock is determined in part by the stability and the degradation rate of PER and
CRY (Buhr & Takahashi, 2013).

(Cho, 2012)
Figure 1. Molecular mechanism of the circadian gene regulation. The core clock loop
consists of BMAL1-CLOCK and PER-CRY complexes acting via the E-box. The ROR/REVERB form additional feedback loops. RORs as activators and REV-ERBs as repressors regulate
the expression of BMAL1. D-box, another accessory loop is necessary to maintain the precision
of the clock.

The E-box activation also activates a second feedback loop, in which the Rev-Erbα/β
repressors and RORα/β/gamma activators competes for RORE binding sites present in the
promoter region of Bmal1 (Figure 1) (Cho, 2012). ROR proteins initiates the transcription of
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Bmal1 while REV-ERB proteins inhibit the transcription of Bmal1. This opposing action of
RORs and REV-ERBs are necessary for maintaining the period of circadian rhythmicity. The
third loop is the D-box loop which is required for the robustness of the clock and maintaining the
precision of its period (Takahashi, 2015; Cho, 2012). It is the combined action of the three loops
just described that brings about the approximate 24-hour cycle. The binding elements of the three
different loops act during different time of the cycle to bring about a circadian cycle with a
periodicity of about 24 hours. The E-Box elements act in the morning while the RORE elements
during evening and the D-Box during the day.
In addition to the core clock genes acting in different loops to bring about the circadian
cycle, numerous modulators affect the function of the clock in different cell types. (Takahashi,
2004). These clock-regulating genes are the clock modifier genes. Zhang et al. (2009) conducted
a whole genome screen using RNAi in human U2OS cells to identify clock modifier genes.
Knockdown of more than 25,000 genes in the human genome was done using siRNA and the
effect on the clock was studied. Changes in the amplitude and period length of the clock was
noted for nearly 1,000 knockdown genes. Along with the knockdown study, protein interaction
studies showed direct interaction of some of the proteins encoded by these genes with the core
clock components while other interactions were indirect through bridging molecules. This study
showed the functional interconnectedness of the clock with many other biological pathways
(Zhang et al., 2009) (figure 2). This led to the continued study of clock modifier genes in our lab
focusing on nearly 300 genes with the strongest knockdown clock phenotypes.
My study focuses on one of these modifiers, Cklf, along with Cry2, a core clock gene.
Cells in which Cklf has been downregulated exhibit short period and low amplitude phenotype
(figure 3) (Zhang et al., 2009; Ramanathan et al., unpublished). Cklf is one of the several
3

chemokine-like gene. Its chromosomal location is unique as it is one of the three chemokine
genes located on human chromosome 16 while most of the 40 or so chemokine genes are
located on chromosome 17 (Wenling et al., 2001). Cklf is a type of CC chemokine among the
four distinct types of chemokines identified. The nearly 40 different chemokines are classified
into four different types based on the cysteine motifs in the amino acid sequences. The four types
are CXC, CC, CX3 and C. CXC is also called alpha chemokine to indicate that there is an amino
acid separating the two cysteine motifs.CC chemokines do not have any amino acid separating
the cystines and are also called beta chemokines. The C-type is also called gamma chemokine
and has one cysteine at the N-terminus and one at the C-terminus. CX3 has three amino-acids
between the two cysteines (Murdoch and Finn, 2000).
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(Zhang et al., 2009)
•
•
•
•
•

Green -short period hits
Red-long period hits
Purple-high amplitude
Blue-clock components
Pink-common interacting proteins

Figure 2- The expanded clock gene network. The interactions of the various clock
modifiers (represented by different colors) with the core clock components were
identified. Each color represented a phenotype the clock modifier exhibited as shown
above
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Bioluminescence

Days
(Ramanathan et al., unpublished)
Figure 3. Bioluminescence data of shRNA downregulation of Cklf. shRNA mediated
downregulation of Cklf caused shortening of period length and decrease in amplitude of
circadian bioluminescence rhythms as indicted by green (sh356) and blue (sh357) in MMH-D3
hepatocytes. The difference in the period length and amplitude between the two sh RNA used
can also be noted.

However, Cklf also differs from other CC chemokines as the mature protein contains only
one conserved CC motif but no additional C residues in the C terminus which is present in other
CC chemokines. Hence, it is considered a chemokine-like factor rather than a true chemokine
(Wenling et al., 2001). The product of the gene is a chemotactic cytokine, a small protein with
molecular weight between 5 to15 kDa that acts as a chemoattractant for lymphocytes, monocytes
and neutrophils and also stimulates the proliferation of myoblasts. Cytokines are involved in
many immune and inflammatory processes. Cytokines include interleukins, interferons, tumor
necrosis factors and chemokines. Cklf being a chemokine, exerts its action through G- protein
coupled receptors. Approximately 20 chemokine receptors have been identified and are named as
6

CCR (chemokine receptor)1-20. Among these receptor Cklf exerts its action through CCR4
receptor. (Mantovani, 1999; Murdoch and Finn, 2000).
The interaction between the circadian and the immune system is bidirectional (Dumbell,
Matveeva, & Oster, 2016). Numerous studies have shown that the core clock proteins namely
BMAL1, CLOCK, PER and CRY control fundamental aspects of the immune system (Curtis,
Bellet, Sassone-Corsi, & O’Neill., 2014). Bmal1 gene deletion in monocytes, macrophages and
granulocytes resulted in these cells losing the rhythms of cytokine response (Gibbs et al., 2012).
LPS injection in Cry1/Cry2 double KO mice increased cytokine expression (Narasimamurthy et
al., 2012). Studies have also shown reciprocal interaction. In a study the levels of cytokines
exhibited circadian variation (Scheiermann, Kunisaki, & Frenetterring, 2013). Cytokines such as
interleukins 1 and 6, and tumor necrotic factor α stimulate the hypothalamic pituitary axis to
produce glucocorticoids which in turn act on immune cells to suppress proinflammatory
responses (Pollmächer et al., 1996). Inflammation and infection can disrupt the expression of the
core clock genes (Logan & Sarkar, 2012). Cklf, being a chemotactic cytokine, is involved in
immune mediation and is increased in autoimmune and inflammatory diseases such as
rheumatoid arthritis and asthma. In the case of asthma, the increase in the inflammatory response
is by the stimulation of NF-kB signaling pathway by Cklf through activation of CCR4 receptor
(Li et al., 2014). This increase in inflammatory response is increased during the wee hours of the
morning suggesting a circadian variation (Durrington, Farrow, Loudon & Ray, 2013).
The studies described above show interconnectedness between the immune signaling and
the circadian clock pathways. This led us to further study the effect of Cklf knockout on the
function of the circadian clock, which will advance our understanding of the functional
intersection of the circadian clock and Cklf pathways. To this end, in this project, we aimed to
7

create Cklf knockout cell lines, as well as Cry2 knockout as a positive control, using type II
Crispr/Cas9 gene editing tool in MMH-D3 cell lines to obtain knockout cell lines with which to
study the role of Cklf in regulating clock function.
Significance
Previous shRNA down-regulation studies on Cklf conducted in our lab have shown that
down-regulation of this gene induces low amplitude and short period length phenotypes in U2OS
and MMH-D3 reporter cell lines (Zhang et al., 2009) (Ramanathan et al., unpublished, figure3).
These results suggest that Cklf may influence the core clock components in the generation of
oscillatory rhythms and paved the way for me to further understand the relationship between Cklf
and the clock mechanism. With the interconnectedness between the circadian clock and the
immune system, knockout of Cklf may provide important insights into the interaction between
the chemokine Cklf, an immune regulator and the clock gene network, as well as on how the
immune system regulates the circadian clock. To progress toward this goal, my work focused on
establishing cell lines in which the expression of Cklf and Cry2 (as a known clock gene control)
were permanently deleted using the Crispr/Cas9 gene editing tool.
Hypothesis
The Crispr/Cas9 gene editing tool will enable establishment of cell lines in which Cklf is
deleted from the cell’s genome, and these cell lines will be useful for functional studies of the
role of Cklf in the circadian cycle.
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Materials and Methods
Design to knockout Cklf and Cry2 using the Crispr/Cas9 gene editing tool
The Crispr/Cas9 system is an efficient gene editing tool adapted from adaptive immune
system in prokaryotic cells which consists of a single guide RNA (sgRNA) that directs the Cas9
endonucleases at specific genomic locus to produce a double strand break (Bauer et al., 2015).
The Streptococcus pyogens derived Cas9 is an endonuclease which creates double stranded
break as the sgRNA recognizes specific targets in the genomic DNA sequence via Watson and
Crick base pairing. The resulting double stranded break is repaired by non-homologous end
joining (NHEJ). Non-homologous end joining is the double stranded break repair occurring
without a homologous template causing frameshift mutations leading to nonsense mediated
decay of the mRNA transcripts (Bauer et al., 2015).
Two sgRNAs were designed manually to target portion of exon 1 and 2 of Cklf (mus
musculus, accession number NC_000074.6) and exon 7 and 9 of Cry2 (mus musculus, accession
numberNM_009963.4). The sgRNA consists of 20mer protospacer sequence upstream of the
NGG sequence which is the protospacer adjacent motif at the genome recognition site of Cklf
and Cry2. Each guide had 24-25 mer oligos along with the reverse complement. (Bauer et al,
2015). The sequence of the sgRNA used are shown in Table 1.
Table 1.
Gene

Exon

sgRNA

Sequence

Cry2

Exon 7

Forward

CACCGCCCCTCCATTCGGTCAAACC

Reverse

AAACGGTTTGACCGAATGGAGGGGC

Forward

CACCGCATGATTGACGATGGGCCGT

Reverse

AAACACGGCCCATCGTCAATCATGC

Exon 9
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Table1. (continued)
Cklf

Exon 1

Exon 2

Forward

CACCGCACGGCCGGTCGTAAGCCGT

Reverse

AAACACGGCTTACGACCGGCCGTGC

Forward

CACCGTCCACACGTGTATAAGACT

Reverse

AAACAGTCTTATACACGTGTGGAC

pX459 vector from Addgene (plasmid ID 48139) with BbsI restriction enzyme site was
used to ligate the sgRNA designed for each of Cry2 and Cklf after restriction digestion with Bbs1
(5000 U/ml). pX459 also encodes a puromycin-resistance element as a selectable marker.
Primers were designed manually to detect the deletion by PCR and verified using freely available
MIT Crispr Designing tool. One set of primers for each of Cry2 and Cklf were designed internal
to the sequence to be deleted called as the non-deletion band. Another set of primers external that
is upstream and downstream to the site of cleavage of Cry2 and Cklf termed as delete band were
also designed (figure 4). The sequences to delete region were designed 100 bp away from the site
of cleavage so that the small indel at the sgRNA target site would not impact the detection of
deletion.

(Bauer et al., 2015)
Figure 4- Primer design to detect KO clones. The red arrows indicate the primers to detect the
desired deletion and the blue arrow indicate the primers designed to detect the non-deleted
portion for both Cry2 and Cklf.
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Table 2.
Gene

Primers

Cry2-delete

Forward 5’-GAACCATGGCGATTGGGAGA-3’
Reverse

Cry2-non-delete

5’-TAGGGTACCCCAATCCAGGAG-3’

Forward 5’-CGCCTACTCCAACAGTGCTT-3’
Reverse

Cklf-non-delete

5’-ATCTTTTACAGCCTGGGGGC-3’

Forward 5’-GACGCCATCATGACCCAACT-3’
Reverse

Cklf-delete

Sequences

5’-AAGGTCAGCCATACCTACTGGT-3’

Forward 5’-GACGCAAGGCATTGATTGCT-3’
Reverse

5’-CCCTGGCCGTTTGTACTTCT-3’

Cloning of oligos of Cry2 and Cklf
Synthetic oligos for Cry2 and Cklf were cloned into pX459 vector as follows. Oligo
synthesis was performed by Integrated DNA technologies. The oligos for Cry2 and Cklf were
briefly spun and resuspended at a final concentration of 100µM in distilled water. For annealing
reaction of 50 ul, 1.5 µl of forward oligo (100 uM), 1.5 µl of reverse oligo (100 uM) for each of
Cry2 and Cklf, 5 µl of 10X NEB buffer 2, 42 µl ddH2O was used. Annealing was carried out at
95°C for 5 min followed by 70°C for 10 min and cooled gradually by placing the oligo solution
in a water bath, unplugging the machine.
The annealed oligos were then used for serial dilution to 500 nM so that the
stoichiometry between the oligo and the vector is captured. pX 459 vector was digested with
Bsbs1 enzyme. 20 µl reaction was used for digestion with Bbs1 restriction enzyme 0.4 µl, buffer
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2.1 2µl and 3.7 µl dd H20 at 37°C for 4 hours. Fragments were purified by 1% agarose gel. The
open vector was extracted by gel purification. The DNA fragments were cut and resuspended in
750 µl of QG buffer (5.5 M guanidine thiocyanate, 20 mM Tris-HCl, pH 6.6 (25ºC), dissolve in
water (pH 7) in an eppendorf tube. The tube was placed in heat block at 42ºC for 10 minutes.10
µl sodium acetate was added into the tube and mixed gently till the solution turned yellow. The
solution was poured into a mini prep column (Quigen) and allowed to stand for 5 minutes. The
column was washed with 500 ml of PE buffer. The column was placed in collecting tube and
centrifuged at 14,000 rpm for 1minute. The prep columns were then placed in a clean sterile
1.5ml micro centrifuge tubes. DNA was eluted by adding 40 µl of extraction buffer to the center
of the prep spin column and allowed to stand for one minute. The tubes were then centrifuged at
10,000rpm for 1 minute. The elute was run again on 1% agarose gel for confirmation. Ligation
was carried out at 16°C for 4 hours with1 ul of 10X ligase buffer, 0.2 ul ATP, 1 ul of annealed
oligo pair, 2 ul of vector, 1 ul T4 ligase and H2O to adjust the volume to 20ul.
One µl of the ligation reaction was then transferred to 50µl Mac E coli cells and plated
onto lysogeny broth (LB) agar plate with 100µg/ml of ampicillin and incubated overnight at 37
°C. 2-3 colonies for each of the Crispr-Cas9 construct of Cklf and Cry2 were picked and
inoculated into mini-prep culture using LB media. 2-3 colonies for each of the crispr-cas9
construct of Cklf and Cry2 were picked and grown in LB media by placing in a shaker overnight.
The following day the tubes were removed from shaker and centrifuged at 3,600rpm for 10
minutes. The supernatant was poured out and the precipitate of bacterial cells at the bottom was
resuspended in 250 µl of P1 buffer and transferred to a microcentrifuge tube. The content was
vortexed. 250µl of buffer P2 and the tubes were gently inverted 4-6 times to mix the content
until the solution becomes viscous and slightly clear. Then, 350µl of buffer N3 was added and
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the tubes were inverted gently 4-6 times until cloudy. The solution is centrifuged at 15,000rpm
for 10 minutes. The supernatant is poured in prep spin column placed on top of a 2-ml collection
tube to allow the flow through. The columns are placed in a vacuum column to allow for the
solution to flow through. 750 µl PE buffer was then added to the columns. The columns were
centrifuged at 15,000 rpm for one minute. The prep columns were then placed in a clean sterile
1.5 ml microcentrifuge tubes. DNA was eluted by adding 40µl of extraction buffer to the center
of the prep spin column and allowed to stand for one minute. The tubes were centrifuged at
10,000 rpm for 1 minute. The concentration of the eluted DNA for each of the plasmid of Cry2
and Cklf were measured at 260 nm. The plasmid was digested with Bbs1 restriction enzyme and
run on agarose gel. Bands of Cklf and Cry2 constructs were sliced out from the gel and their
nucleotide sequences was determined by Sanger sequencing at the University of Tennessee
Health Science Center.
Transfection of Crispr/Cas9 constructs into cell of interest
The sequence verified plasmids encoding Cklf and Cry2 were transfected using the
liposome-based reagent lipofectamine 2000 (Invitrogen) into 60-70% confluent MMHD3(murine
hepatocytes) reporter cell lines grown in RPMI culture media (Hyclone) in 6 well culture plates
coated with type I collagen in DPBS(Fischer). (40µl of collagen dissolved in 1ml of DPBS). The
RPMI media was supplemented with 50ml of 10% fetal bovine serum, 16 ng/ml insulin like
growth factor-II (IGF-II), 55ng/ml of epidermal growth factor (EGF), 10 µg/ml of insulin, 5 ml
of 1x streptomycin-glutamine-penicillin. The transfection was carried out at a ratio of 1 µg of
DNA:2 µg of the transfecting agent. 2 µg of each Crispr-Cas9 plasmids (total 4µg) of Cklf and
Cry2 was used for transfection (n=2 for each of Cry2 and Cklf).
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EGFP expressing construct was used as control to check for the transfection efficiency.
EGFP constructs were transfected using liposome-based transfection method into WT MMH-D3
reporter cell lines (n=1). The day following transfection fresh RPMI media with 10% serum was
replaced into each well containing the transfected and the control cells and incubated at 37°C
overnight. On day 2 following transfection, the transfection efficiency was evaluated in the
EGFP control cells using fluorescence microscopy. When the cells reached 100% confluence, the
cells transfected with Cry2 and Cklf were detached with trypsin and transferred into a 10 cm type
I collagen coated culture plate and grown in RPMI media containing 10% serum. Puromycin
(1µg/ml of RPMI media) was added to the medium to select for transfected cells. A kill curve
was plotted to determine the concentration of puromycin to be used. Different concentrations of
puromycin ranging from 0.5 µg/ml to 5 µg/ml were initially used to determine the concentration
of puromycin to be used as selection marker. The lowest concentration that was effective in
killing all the cells on day 5 was selected. The selected concentration was 1µg/ml.
Single cell sorting
On day 5 after antibiotic selection, the puromycin-resistant cells of both Cry2 and Cklf
which could represent possible cells which have received the CRISPR-Cas9 construct were used
for sorting into 96 well plates. The cells in the 10 cm plate of Cry2 and Cklf were washed with 2
ml of DPBS and 1 ml of trypsin was added into each of the plate and incubated at 37°C for 3-4
minutes. 2 ml of RPMI media with 10% serum was added into each of the plate to stop
trypsinization. The cells were collected in a 15 ml tube and centrifuged at 2,500rpm for
5minutes.The trypsin with RPMI media was aspirated out. The pellet was resuspended in 6 ml of
RPMI media and the number of cells were counted using a cell counter. Approximately 300,000
cells/ml of Cry2 and Cklf were serial diluted to achieve 1 cell per well into a 96 well plate. The
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plate was coated with type I collagen (n=5-15 plates/ gene). 150 microliters of RPMI media with
10% serum was used for each well to grow single cell clones. The single cell clones were
allowed to grow for 7-8 days with a change of media on day 4 (n= 4-6 clones per 96 well plate).
The possible single cell clones were then collected after 8-10 days (cells were 100% confluent)
by trypsinizing with 20l of 0.05% trypsin-EDTA solution after aspiration of the media and 100
μl was transferred to two 96 well plates containing 150μl of RPMI media per well. One 96 well
plate was used for growing the cells for further passaging into larger dishes while the other plate
was stored using storage media for MMH-D3 cells (90% serum and 10%Di methyl sulfoxide
DMSO) at 80°C for further use. Each of these single cell clones of Cry2 and Cklf from 96 well
plate was then transferred to 48 well plate once 100% confluent. The cells could grow till 100%
confluent and then transferred to two 24-well plate. One for genotyping and the plate for further
use in immunoblots and bioluminescence recording. Once the cells in 24 well plate were 100%
confluent, the cells were trypsinized and seeded into 12-well and later into 6-well plates. The
100% confluent cells in one of the 6 well plate was used for genomic DNA extraction (see
below). While the cells in the second plate were grown for immunoblotting and bioluminescence
studies.
Genomic DNA extraction
The 100% confluent cells were washed with DPBS, trypsinised using 20μl of 0.05%
trypsin-EDTA solution and collected into 1 ml Eppendorf tube prior to centrifugation at 1,000
rpm for 1 minute. The solution was aspirated, and the cells were washed with DPBS and
centrifuged at 1,000 rpm for one minute. The DPBS above the cell pellet was aspirated with a
pipette connected to a vacuum line. The cell pellet was then used for DNA extraction. The DNA
extraction solution was made of 25 ml of 20 mM of Tris chloride pH 8.8 and 250 microliter of
15

Tween 20. 250μl of DNA extraction solution and of proteinase K were added to the cell pellet
and mixed thoroughly by pipetting up and down. The cell lysate was then placed on heat block at
55°C for 45 minutes and for 95°C for 10 minutes to extract the genomic DNA. The cell lysate
was cooled at room temperature and stored at -200C for screening of Crispr/Cas9 mediated
deletion (Bauer et al., 2015).
Screening of Crispr/Cas9 mediated deletion and clone selection
Five μl of genomic DNA of each clone was taken after centrifuging at 1,000 rpm for 1
minute into a single eppendorf 1.5 ml tube to get polyclonal population of the clones. This
polyclonal population of clones was used for standardizing the PCR conditions for each pair of
primers designed for Cry2 and Cklf clones. Primers were validated from bulk sorted cells
composed of polyclonal population of cells exposed to the sgRNA. This was done to verify the
presence of intended genomic deletion in addition to standardizing the PCR conditions. A 10 µl
PCR reaction with the forward and reverse primer (1µl each), taq polymerase (0.2µl) genomic
DNA of the polyclonal population (2 µl), 5x buffer (2µl) and water was added to a final volume
of 10 µl. PCR was then carried out for 40 cycles using the following parameter 95°C for 15 min,
95°C for 30 sec, 60°C for 1 min, 72°C for 1 min, and 72°C for 10 min. The samples were then
analyzed on 2% agarose gel using 1X Tris-acetate-EDTA (TAE) buffer.
Screening of the monoclonal cell lines for Cry2 and Cklf deletion was carried out with the
standardized PCR condition described above for non-deletion and deletion bands. The samples
were run on 2% agarose gel using 1X Tris-acetate-EDTA (TAE) buffer.
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Bioluminescence recording
Three 35 mm culture dishes for each of the KO or biallelic deletion clones, monoallelic
deletion or HZ (heterozygous clones), WT clones of Cry2 were used for bioluminescence
recording. Each dish was type I collagen coated and the KO, monoallelic deletion, WT cells were
seeded and grown in RPMI medium with 10% serum. These dishes were incubated at 37°C until
the cells in each of the 35 mm dish were 100% confluent. The confluent cells were synchronized
with synchronizing media (RPMI with dexamethasone) and incubated for 2 hours at 37°C. Next,
cells were placed in recording media. The recording media was made of 10X DMEM (Hyclone),
25 mM HEPES, sodium bicarbonate, 1x Pen/Strep/Gln, 1 mM luciferin, sodium hydroxide, B27, 1 mM Luciferin, p-27 and hypure water.
The dishes were then sealed with 40 mm thick sterile coverslips using vacuum grease to
prevent evaporation. The dishes were loaded into lumicycle luminometer (version 2.31,
Actimetrics) kept inside an incubator set at 36°C without water or CO2. Real-time
bioluminescence recording was performed for 1 week to determine the amplitude and periodicity
of the circadian circle of the KO, HZ and WT cell lines of Cry2. The lumicycle uses
photomultiplier tubes for light detection emitted from the cells. These photomultipler tubes have
the advantage of detecting very dim luciferase bioluminescence. The data on the first day is
excluded because of high transient bioluminescence on change of media. Lumicycle Analysis
program version 2.53 (Actimetrics) was used for data analysis of circadian parameters.
Immunoblots
The KO, HZ and WT single cell clones of Cry2 were further characterized by
immunoblotting to evaluate Cry2 protein levels. The KO, HZ and WT cells of Cry2 were grown
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in 6 well plate in RPMI media until 100% confluent. The confluent cells were washed with
DPBS and lysed using ice cold lysis buffer RIPA. The cell suspension of the KO, HZ and WT
was then transferred into a cooled microcentrifuge tube and agitated constantly for 30 minutes at
4°C. The cells were centrifuged at 12,000 rpm for 10 minutes after which the supernatant was
removed and placed in a new tube and the pellet discarded. The samples were denatured by
placing at 100°C for 5 minutes. 10µg proteins were loaded and separated using SDS-PAGE
along with a molecular marker. The gel was run for 2 hours. Once the proteins got separated on
the gel due to the negative charge imparted on the protein by the ionic SDS detergent, transfer
onto nitrocellulose membrane was done by the sandwich technique. In this technique the gel is
directly in contact with the nitrocellulose paper. The transfer involves the use of porous pads and
filter paper. The transfer of proteins from the gel onto the nitrocellulose paper takes place on
application of current. The membrane is washed with dd water and blocked using blocking
buffer. (1X TBST with 5% nonfat dry milk) for one hour. Cry2 primary antibody (1:1000
dilution) (Santa Cruz) is added and the membrane incubated overnight at 4°C. The following day
the membrane is washed with three washes of TBST, 5 minutes each time. Secondary antibody
conjugated to peroxidase is diluted in blocking buffer (1:1000 dilution) was added to the
membrane and incubated for one hour. Chemiluminescence is used to detect the required signals.
Alteration in the design of Crispr/Cas9
To improve the efficiency of detection of KO clones, we modified the design of Cklf
Crispr/Cas9 approach (figure5). We used two fluorescence proteins each one attached to one
sgRNA Px458 vector, in which sgRNA was ligated at the BbsI restriction enzyme site, and
fluorescence proteins were used as FACS sorting marker. Two sgRNAs were designed to
knockout the entire coding portion of Cklf by Dr. Stephane Pelletier, in collaboration with Dr.
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Doug Green, at St Jude Children’s Research Hospital as previously described (Pelletier et al.,
2015). One sgRNA had GFP as a selectable marker and the other had m-cherry as a selectable
marker. This gave higher chance of detecting the possible knockout gene by screening the cells
which received both GFP and m-cherry Crispr/Cas9 constructs (figure 8). The cloning,
transfection method and screening of the Crispr/Cas9 mediated deletion and non-deletion was
similar as described above. However, the transfection efficiency was evaluated using confocal
microscopy at the Integrated Microscopy Center at the University of Memphis. The transfected
cells of Cklf were screened individually for GFP and m-cherry. The preparation was screened for
cells which fluoresced both in the red and green channels, making them appear orange-yellow,
because these were the possible good candidates for having successfully incorporated the
Crispr/Cas9 construct.

Figure 5. Design to knock out Cklf. One guide (Cklf guide 1) has m-cherry as selection marker
and the other guide (Cklf guide2) has GFP as the selection marker. F51 and F31 are forward
primers to detect the KO and the WT clones. R52 and R32 are reverse primers to detect KO and
WT clones of Cklf. The design includes the variants of Cklf along with all the 4 exons.
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Fluorescence activated cell sorting (FACS) was used to sort the transfected cells. FACS
enriches the cells that received high levels of the Crispr/Cas9 constructs into 96 well plate
containing 150 μl of RPMI media (n=20). The single cell clones were then transferred into a
single 96 well plate which were further transferred to 48-well plate and then to 24-well plate and
12-well plates followed by 6-well plates. This was followed by gDNA extraction as described
above, followed by genotyping as described for Cry2. But as the results were not consistent we
changed the method of DNA extraction.
Alternative method of DNA extraction
The cells were washed with DPBS and trypsinised. RPMI media was added to stop
trypsinization and the cells were collected in 1 ml microcentrifuge tubes. The tubes were
centrifuged and the trypsin along with RPMI media was aspirated by an aspirator. The cells were
again washed with DPBS and centrifuged. DPBS was aspirated with a pipette connected to a
vacuum line and the pellet was suspended in DNA lysis buffer with proteinase K. We used DNA
lysis buffer made of 100 mM Tris, pH 8, 5 mM EDTA, 0.2% SDS, 200 mM sodium chloride.
300 microliters of this DNA lysis buffer with 5 microliter of proteinase K was used for a 100%
confluent cells in a 6-well plate. The cells were placed at 55°C in a heat block for one hour. The
tubes were then centrifuged at 13,000 rpm for 10 minutes. The supernatant was collected in a
fresh tube to which equal amount of isopropanol as the DNA lysis buffer was added and mixed
gently. These tubes were centrifuged at 13,000rpm for 10 minutes. The supernatant was
discarded, and the pellet was mixed 300 microliters of 70% ethanol. This was again centrifuged
at13,000 rpm for 10 minutes. The supernatant was discarded with the DNA pellet at the bottom.
This was then air dried for 10-15 minutes. The pellet was resuspended in 30 microliters of TE
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buffer. These tubes were then incubated at55°C for 30 minutes and were used for genotyping as
described above. The extracted DNA was stored at -20°C for further use.
Results
Screening of Crispr/Cas9 Cry2 and Cklf clones for deletion and clone selection
As an initial effort to develop knockout cell lines of Cry2 and Cklf we used the latest
Crispr/Cas9 system (Bauer et al., 2015). We attempted to develop these cell lines to study the
functional interaction between the circadian clock and the immune mediator Cklf.
We first identified an appropriate target site for Cry2 represented by exons 7 and 9 which are
functionally important exons for regulating the circadian clock (NCBI website) and for Cklf,
exon 1 and 2 which are the exons common for all the 4 variants of Cklf (NCBI website). MMHD3 cells were transiently transfected with liposome-based reagent with pX459-Cry2 sgRNA
plasmid and Px459-Cklf sgRNA plasmid in two separate wells of a 6 well culture plate. A
transfection efficiency of 70% was obtained for the generation of Cry2 and Cklf KO clones
which was evaluated using EGFP transfected into MMH-D3 cells (figure 6). The transiently
transfected Cry2 and Cklf puromycin resistant MMH-D3 cells were sorted into 96 well plate for
single cell cloning. The expanded single cell clones of Cry2 and Cklf were used for gDNA
extraction and a polyclonal cell population was derived by mixing 5 µg of each of the single cell
clones in an eppendorf tube. This polyclonal population of cells of Cry2 and Cklf was used for
PCR standardization. The Cry2 gDNA polyclonal cells had a delete band at 370 bp which is for
the wild type allele and a non-delete band at 546 bp representing a possible knockout allele
(figures 7 and 8).
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Screening of single cell clones of Cry2
The gDNA of single cell clones were subjected to screening for Cry2 KO cell lines once
PCR was standardized. We screened 150 single cell clones of Cry2. The single cell clones of
Cry2 were screened for the presence or absence of the delete band (370 bp) and the non-delete
band (546 bp) (figure 9). The clones which gave only delete bands(370bp) without non-delete
bands were considered as KO clones while the clones considered as heterozygous or monoallelic
deletion had both the delete (370 bp) and the non-delete (546 bp) bands. This indicates that
Crispr/Cas9 non-deleted allele is imperfectly edited by indel formations meaning one allele of
the gene was deleted while the other allele of the gene was not deleted during non-homologous
end joining repair. The single cell clones with biallelic deletion or the KO clones of Cry2 had a
band at 370bp and did not have the non-delete band at 546 bp. We obtained 7 Crispr/Cas9
homozygous knockout (KO) and 2 heterozygous (HZ) Cry2 clones. Each of the 7 KO clones and
2 HZ clones of Cry2 were reconfirmed for the presence or absence of the delete and non-delete
bands by repeating the PCR and running the PCR amplicons on agarose gel (3 times). The 7 KO
and 2 HZ clones of Cry2 were allowed for expansion for 5 days in RPMI media. In all cases the
PCR results confirmed the results of the indel analysis. The gel extraction of KO clones and the
HZ clones was used for characterizing the clones using Sanger sequencing. Sequencing results
confirmed the KO, HZ and WT clones of Cry2. The KO sequences exhibited deletion which
encompassed the target site.
Western blots analysis of Cry2 KO, HZ and WT clones
The seven KO clones and two HZ clones along with WT Cry2 clones were probed for
protein expression by Western blots (Figure 10). The decrease in the amount of protein in the HZ
Cry2 clones and the absence of proteins in the KO Cry2 clones was noted relative to the WT.
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This result validated the Crispr/Cas9 KO, HZ Cry2 clones and shows that in the KO clones Cry2
expression was completely abrogated.
Crispr/Cas9 KO of Cry2 in MMH-D3 cell lines caused lengthening of period length
Seven Cry2 KO clones and one HZ Cry2 clone along with WT clone were used for
recording the circadian rhythms in these cells using Lumicycle luminometer (Actimetrics). The
lumicycle analysis program version 2.53 (Actimetrics) was used to determine circadian
parameters. Circadian period phenotype of monoallelic deleted clones and KO Cry2 clones in
comparison to the WT cells were recorded using real time bioluminescence (Figure 9). The
period lengths for the KO clones were 1.5-3.5 hours longer than the WT clones (approximately
24 hrs). These individual KO clones exhibited variation from 25.5to 27.5, compared to
approximately 24 hours for the WT clones (Figure 8 and 9).
The magnitude of period change in homozygous KO clones of Cry2 was significantly
longer (27 .5) than WT (approximately24 to 24.5). However, the HZ KO clones exhibited
modest change in period (long period phenotype (26 .5) in comparison to the KO clones (figures
11,12). This data is consistent with the essential role of Cry2 in maintaining the period length of
the clock to approximately 24 hours.
Screening of single cell clones of Cklf
Attempt 1
We obtained 600 single cell clones of Cklf gene deletion clones. A polyclonal population
of cells of Cklf was used for screened for the presence or absence of delete band (560 bp) and the
non-delete band (429 bp) (Figures 13,14) for PCR standardization. This was followed by single
cell clone screening of Cklf clones which gave us one KO clone and 4 heterozygous or the
monoallelic deleted clones (figure 15) and the remaining were non-delete clones. The single KO
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clone and the 4 HZ clones were again genotyped, but the clones gave us smears which could
have been due to possible contamination. To this end we grew single cell clones of Cklf again
but were unsuccessful to detect a KO clone. This led us to alter the Crispr/Cas9 design by using
two fluorescence proteins, each attached to one sg RNA as described above and targeted the
entire coding portion of Cklf
Developing an alternative Crispr/Cas9 protocol to obtain Cklf KO cells
Attempt 2
With the Crispr/Cas9 design described above we were able to successfully knock out
Cry2, but not Cklf. We improved the experimental design used to obtain and detect KO clones of
Cklf. Two sgRNAs were ligated with two different fluorescence markers. One sgRNA was
ligated with GFP and the other with m-cherry. This was designed so that the cells receiving both
the sgRNA would have yellow fluorescence. The use of two markers would increase the chance
of detecting cells transfected with Crispr/Cas9 Cklf constructs by using FACS which screens for
cells receiving yellow fluorescence. Liposome-based transfection was used as described above.
Two wells of the 6-well plate were used for transfection. Each well was screened for GFP
(figure16) and m-cherry (figure16) fluorescence individually. The cells which expressed both
fluorescence markers appear yellow (figure 17) and were considered to have received
Crispr/Cas9 Cklf construct. The transfection efficiency was calculated as described above and the
transfection efficiency of 30% was obtained (figure 16). The cells were then sorted into 96 well
plates (n=20) using FACS to enrich for the top 3% of the cells positive for both fluorescent
markers. Each plate had 15-20 single cell clones which were expanded over a 7 days period. 350
single cell clones from 20 plates were used for gDNA extraction. These single cell clones of Cklf
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were screened for deletion (no band) and non-deletion (463bp and 603bp) bands. Polyclonal cells
were pooled as described above for Cry2 and Cklf and used for PCR standardization.
However, during the standardization procedure, we obtained only non-specific bands and
the results for the delete region and non- delete region were inconsistent (figure 17). This
prompted us to take a critical look at the properties of the primers used. One of the primers used
had GC content greater than 60% and so we selected new primers manually and verified their
properties with the software Primer Blast. The newly designed primers were used for
standardization of the polyclonal cell population of Cklf (figure 18). The polyclonal clones gave
us both delete and non-delete bands. Once standardization was achieved, PCR was carried out to
screen Cklf single cell clones. The PCR amplicons exhibited nonspecific bands and inconsistent
results were obtained for the delete and the non-delete regions each time the PCR was repeated
(figure 19).
Attempt 3
We once again carried out single cell seeding into 96 well plates using FACS to obtain
more clones. We obtained 400 clones and performed genotyping to detect delete and non- delete
Cklf clones.in this attempt we tried an alternative method of DNA extraction as described above
to our surprise, the results were again inconsistent with non-specific bands and variation in the
results of the delete and non-delete regions each time the PCR was repeated (figure 19). The
variation consists of either smear, absence of the delete and the non-delete band or non-specific
bands. This result suggests standardizing the PCR conditions for further screening of single cell
clones of Cklf.
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Figure 6. Fluorescent image of transfected EGFP expressing MMH-D3 reporter cells. This
was used to check for the transfection efficiency as indicated by the EGFP expression in these
cells.
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Figure 7. Genotyping of Cry2 polyclonal clones for primer validation and verifying the
presence of deletion amplicons. Polyclonal Cry2 clones were used with different buffers. Each
lane represents a different buffer. The different buffers are marked in alphabetical order. The
band at 370 bp represents the deletion amplicons.
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Figure 8. Genotyping of Cry2 polyclonal clones for primer validation and verifying the
presence non-deletion amplicons. Polyclonal Cry2 clones were used with different buffers.
Each lane represents a different buffer. The different buffers are marked in alphabetical order.
The bands at 546 bp represents non-deletion amplicons.
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2500
1500
1000

Non-delete
500

Delete

Figure 9. Genotyping of individual Cry2 clones for non-deletion, monoallelic, and biallelic
clones. Each lane represents individual clones amplified by PCR and labelled as KO for
knockout/biallelic clones and HZ for monoallelic deletion clones screened using primers. The
band at 370 bp represents the KO/ biallelic deletion amplicons of Cry2 while the band at 546 bp
along with the band at 370 bp represents the represents the monoallelic amplicons.
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WT-Wild type
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HZ KO WT HZ WT KO KO KO KO KO

HZ-Heterozygous/
monoallelic deleted clone
KO-Knockout clone

69

Cry2
Da

55

Figure 10. Western blot of WT, HZ and KO Cry2 clones. Data shown is representative of
three independent experiments. Cry2 WT, HZ and KO protein in 10μg of whole cell lysate from
MMH-D3 hepatocytes. A decrease in the amount of protein in the monoallelic (HZ) Cry2 clones
and the absence of proteins in the KO Cry2 clones was noted relative to the WT.

Period length (hr)

HZ-Heterozygous/monoallelic
deleted clone
KO-Knockout clone

Figure 11. Lengthening of period length of HZ and KO Cry2 clones. Crispr/Cas9 knockout
studies on Cry2 lengthens the period length of circadian bioluminescence rhythms in MMH-D3
hepatocytes. Bioluminescence data are presented as an average of three independent experiments
for each clone. The magnitude of period change in homozygous KO clones of Cry2 was
significantly longer (period phenotype (27.5)) comparison to WT (24.5). However, the
monoallelic KO clones exhibited modest change in period (long period phenotype (26.5) in
comparison to the KO clones (27.5).
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WT- Wild type
Hets-Heterozygous/monoallelic
deleted clone

Period length(hr)

KO-Knockout clone

Figure 12. Lengthening of period length of HZ and KO Cry2 in comparison to WT clones.
The magnitude of period change in homozygous KO clones of Cry2 was significantly longer
(period phenotype (27.5) comparison to WT (24.5). However, the monoallelic KO clones
exhibited modest change in period (long period phenotype (26.5) in comparison to the KO clones
(27.5).
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Figure 13. Genotyping of Cklf polyclonal clones for primer validation and verifying the
presence deletion amplicons. Polyclonal Cklf clones were used with different buffers. Each lane
represents a different buffer. The different buffers are marked in alphabetical order. The band at
560 bp represents delete amplicons.
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Figure 14. Genotyping of Cklf polyclonal clones for primer validation and verifying the
presence non-deletion amplicons. Polyclonal Cklf clones were used with different buffers. Each
lane represents a different buffer. The different buffers are marked in alphabetical order. The
band at 429 bp represents delete amplicons.
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L 1 2 3 4 5 6 7 8 9 10 11 12 13

Figure 15. Genotyping of single cell clones of Cklf. Each lane represents individual single cell
clones. A single band at 546bp represents deletion amplicon/KO Cklf clone while the band at
429bp(delete) along with the band at 546bp (non-delete) represents a monoallelic or HZ deletion
clones of Cklf while the lanes with only band at 429bp represents a WT clone.
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Figure 16. Transfected MMH-D3 cells screened for possible representative areas receiving
Crispr/Cas9 Cklf constructs using confocal microscope. Green fluorescence on the left of the
figure represents the possible cells receiving the GFP Crispr/Cas 9 Cklf construct. Red
fluorescence in the middle of the figure represents the possible cells receiving the m- cherry
Crispr/Cas 9 Cklf construct. Yellow fluorescence represents cells which have possibly received
both GFP and m-cherry Crispr/Cas9 Cklf construct.
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Figure 17. Non-specific bands of polyclonal Cklf FACS sorted cells. Each lane represents the
polyclonal population of Cklf clones screened for deletion and non-deletion amplicons for primer
validation and PCR standardization. The arrow represents nonspecific bands. The different
buffers are represented with different alphabetics below the figure.
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Figure 18. Genotyping of Cklf polyclonal clones for primer validation and PCR
standardization. Polyclonal Cklf clones were used with different buffers. Each lane represents a
different buffer indicated by the different alphabets. The different buffers are marked in
alphabetical order. The expected WT bands were at 463 bp and 605bp which was achieved.
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Figure 19. Genotyping of Cklf single cell clones. Each lane represents a single cell clone of
Cklf screened for KO and WT band (463, 605). All the single cell clones either were smears or
had non-specific bands.
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Discussion
In this study we used the Crispr/Cas9 method in MMH-D3 reporter cell lines to create
KO cell line of Cry2 and Cklf. Our workflow is adapted from previously published methods
(Bauer et al., 2015) and can be divided into four phases:1) guide sequence design and sgRNA
construction, 2) screening of sgRNA, 3) isolation of single cell clones, 4) screening of single cell
clones and validation. Thus, the workflow can be applied to any other cell lines which are used
to study the circadian clock functions.
The rapidly developing RNA programmable gene editing technology can be applied to
knockout a single gene as in this study or can be harnessed for multiple genome engineering
(Cong et al., 2013; Mali et al., 2013). sgRNA targeting distinct sites within the genome can be
co-expressed to knockout multiple genes simultaneously and eliminate redundancy in signaling
pathways. This approach can be used to eliminate other repressor clock genes such as Cry1,
Per1, 2 or clock activator genes such as Bmal1 and Clock and to define the physiological roles of
specific clock network components. The Crispr/Cas 9 system can also be applied to knock-in
point mutations or new sequences into genes by providing a donor DNA template with desired
modification of the sequence. The workflow is the same as described except the introduction of
donor template (Mali et al., 2013). Crispr/Cas9 is an expanding tool currently available for in
vivo and in vitro gene modification. However, the system does have certain caveats such as the
potential off target gene disruption (Kuscu, Arslan, Singh, Thorpe, & Adli, 2014). The short 20
bases guide sequence that directs Cas9 to the target sites could bind to other sequences in the
genome. Hence it is very important to design the guide sequence with a high target specificity.
The seeding sequence which is the 10-12 base pairs adjacent to the PAM or 3’ end of the guide is
a key component adding to the specificity of the target region (Zhang,Tee,Wang, Huang, &
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Yang, 2015). In one of the studies performed using Crispr-Cas9, non-deletion clones were
frequently observed due to indel formation in one of the two alleles and was not just due to the
transfection efficiency to the Crispr plasmids into the cells (Canver et al., 2014). Although Crispr
offers advantages in the simplicity of the design and is a rapidly developing gene editing tool,
several studies have shown that it is not without limitations and drawbacks (Zhang et al., 2015).
Using the above-mentioned method, we successfully generated KO single cell clones of
Cry2 using the Crispr/Cas9 system. Our data, indicate that a sgRNA programmed to a target site
in exon 6 and 7 of Cry2 gene triggers sequence specific Cas9 mediated NHEJ, resulting in
ablation of Cry2 protein expression. The KO cell lines of Cry2 exhibited long period phenotype.
Regarding Cklf we used two approaches to detect for Cklf deletion. In our study we were
successful in obtaining delete and non-delete bands from polyclonal population of Cklf clones
using two different approach as described above. We achieved 4 monoclonal and one KO Cklf
cell lines but the results were inconsistent. The repeated PCR either gave smears or nonspecific
bands which we thought could be due to DNA contamination or degradation of DNA over a
period. This led us to rescreening of new single cell clones but again with inconsistent data. The
low percentage of KO and the screening of non-delete clones of Cklf with inconsistency in the
results obtained may be due to technical difficulties. This can be overcome by improving the
genome editing efficiency such as higher transfection efficiency, expanding flow cytometrybased single cell sorting and cloning, and designing new PCR genotyping strategies.
Confirmation that dysregulation of Cklf affects the circadian clock awaits obtaining Cklf KO
cells. These cells will be important to gain a mechanistic understanding of the interactions
between circadian clock and Cklf and to determine whether there may be uncoupling of the
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activity of the peripheral clock during Cklf induced periods of immune response and
inflammation.
Our data showing that the downregulation of the immune mediator Cklf, induces short
period length (speeding up the clock oscillation) and low amplitude phenotypes (Ramanathan et
al., unpublished) suggest that Cklf and the circadian clock are connected as alterations in rhythm
amplitude and period length are considered to be reliable indicators of clock fidelity. Marked
circadian disruption in the downregulation of Cklf supports the role for Cklf in timekeeping. This
data supports the idea that Cklf has a possible input into circadian loops acting as a critical link
between immune regulation and circadian time keeping. This result may serve as a starting point
to understand the functional interaction between two important biological pathways, namely the
circadian clock and signaling through the immune mediator Cklf.
This observation remains to be investigated in further studies. We believe that Cklf is the
mechanistic conduit interconnecting these two processes. These findings emphasize the
significance of molecular clock and its regulation of rhythmic production by Cklf, a clock
modifier gene which subsequently influence different biochemical pathways involved in various
pathophysiology.
One of the studies done on Cklf, showed that it helped in selective recruitment of
leukocytes by activation of the NF-kB pathway and triggers immunological changes in asthma
(Lin, Staahl, Alla, & Doudna, 2014). However, the timing of the asthmatic attack by the immune
system varies, with the attack worsening in the wee hours of the morning suggesting circadian
dependency (Durrington et al., 2013). Studies done in our lab on NF-kB indicated that this
pathway plays a significant role in regulation of the clock gene network. These findings suggest
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that Cklf and circadian clock may act via NF-kB as a common pathway. This finding requires
further studies to be carried out.
Generation of KO cell lines of Cklf would be a step in the process of understanding the
interaction of Cklf and circadian clock. However, delineating a precise regulating mechanism of
action of Cklf would require additional work in further studies.
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